文献速递脑血管病外科神经肿瘤

颅内动静脉畸形直线加速器立体定向放射外科治疗队列中照射过量事件的长期随访

Long-term follow-up of an overexposure radiation incident in a cohort treated with linear accelerator-based stereotactic radiosurgery for intracranial arteriovenous malformations.
PubMed 文献 · J Neurosurg · 2022-11-25

该研究对2006年5月至2007年6月因动静脉畸形接受立体定向放射外科治疗时因散射因子估算错误而照射过量的22例患者进行长期前瞻性随访。平均临床随访14.5年,90.9%患者实现畸形闭塞,无放射后出血,13.6%出现新发永久性神经功能缺损,5至15年观察到囊性和出血性晚期病灶(22.7%)。

要点

  • 照射过量后畸形闭塞率达90.9%,平均闭塞时间39.4个月,无放射后出血。
  • 13.6%患者因放射诱导改变出现新发永久性神经功能缺损,81.8%患者无新缺损实现闭塞。
  • 5至15年随访出现囊性和出血性晚期病灶(22.7%),无放射诱导肿瘤。

核心结论

  • 本次长期报告显示,该照射过量事件可能提高了动静脉畸形的闭塞率。
  • 照射过量似乎诱导了放射诱导改变,尤其是较高的囊性和出血性晚期病灶发生率,但临床后果 moderate。
  • 由于晚期放射诱导改变的风险,动静脉畸形需要长期随访。

研究设计与样本

  • 单中心前瞻性随访研究,纳入2006年5月至2007年6月在本部门因动静脉畸形接受立体定向放射外科治疗的22例患者。
  • 患者平均年龄43.5岁(范围11.8-78岁),既往治疗包括栓塞10例、立体定向放射外科1例、手术1例。
  • 平均靶体积2.1 cm³(范围0.2-6.4 cm³),中位处方最小剂量18.0 Gy;因散射因子估算初始错误导致照射过量,中位实际最小剂量25.0 Gy。

主要发现

  • 平均临床随访14.5年(范围12.0-15.2年),90.9%患者实现动静脉畸形闭塞,平均闭塞时间39.4个月(范围24.4-70.4个月)。
  • 无患者发生放射外科后动静脉畸形出血。
  • 3例(13.6%)因放射诱导改变出现新发永久性神经功能缺损;18例(81.8%)实现无新缺损的闭塞。
  • 2例出现可能由放射诱导改变导致的新发癫痫,但控制良好。
  • 中位MRI随访13.8年(范围2.5-14.9年),随访期间观察到两个放射诱导改变时期:前3年经典时期表现为T1加权环形不规则强化(13%),放射外科后5至15年出现囊性和出血性病灶(22.7%);无放射诱导肿瘤病例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Dosimetric radiosurgery incidents are rare and probably insufficiently reported in scientific publications. After a long follow-up (FU), the authors studied the outcomes of patients treated with overexposure radiation for arteriovenous malformation (AVM) administered via stereotactic radiosurgery (SRS) at their department. METHODS: Between May 2006 and June 2007, 22 patients were treated for AVM with SRS. The mean (range) patient age was 43.5 (11.8-78) years. Previous treatments were embolization (n = 10), SRS (1), and surgery (1). The average (range) volume was 2.1 (0.2-6.4) cm3. The median prescribed minimal dose was 18.0 Gy. An initial error in the estimation of scatter factors led to overexposure to radiation. Due to this incident, the median delivered minimum dose was 25.0 Gy. All patients were prospectively followed with clinical examination and imaging. RESULTS: The mean (range) clinical FU was 14.5 (12.0-15.2) years. AVM obliteration after SRS was completed in 90.9% of patients at a mean (range) of 39.4 (24.4-70.4) months. No patient had post-SRS AVM bleeding. Three patients (13.6%) had new permanent deficits due to radiation-induced changes (RICs). Obliteration without new deficits was achieved in 18 patients (81.8%). Two patients had new epilepsy that was probably due to RIC but well controlled. The median (range) MRI FU was 13.8 (2.5-14.9) years. During MRI FU, two RIC periods were observed: one classic period during the first 3 years showed T1-weighted annular irregular enhancement (13%), and the other period between 5 and 15 years after SRS showed the occurrence of cystic and hemorrhagic lesions (22.7%). There were no cases of radiation-induced tumor. CONCLUSIONS: The present long-term report showed that this overexposure incident probably increased the AVM obliteration rate. This overexposure seems to have induced RIC and in particular a higher rate of cystic and hemorrhagic late lesions with nevertheless moderate clinical consequences. Long-term FU for AVM is mandatory due to the risk of late RIC.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Borius PY, Januel AC, Plas JY, et al. Long-term follow-up of an overexposure radiation incident in a cohort treated with linear accelerator-based stereotactic radiosurgery for intracranial arteriovenous malformations. J Neurosurg. 2022. PMID: 36433879. doi:10.3171/2022.10.JNS221763

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。